24/7 Customer Support

Idiopathic Pulmonary Fibrosis Market – Industry Dynamics, Market Size, and Opportunity Forecast to 2030

Global Idiopathic Pulmonary Fibrosis Market By Therapy (Esbriet (Pirfenidone), Ofev (Nintedanib), Tipelukast, Pamrevlumab, KD025, PRM 151, GKT831, Others); By Region (United States, EU5 (Germany, Spain, Italy, France, United Kingdom), and Japan)- Insights, Epidemiology and Forecast– 2030

The Global Idiopathic Pulmonary Fibrosis Market generated US$ 1,915.0 million in 2020 and is estimated to reach US$ 4,298.8 million by 2030, growing at a compound annual growth rate (CAGR) of 9.4%. Read More

We Are Trusted By These Great Companies!
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
sponsor
  • Published On: 30-Jul-2021  |  Format: pdfpowerpointexcel  |  Report ID: AA0721084

Ask For Customization